Re: Zuranolone (SAGE-217) Update.

Posted by undopaminergic on April 22, 2020, at 6:30:22

In reply to Zuranolone (SAGE-217) Update., posted by SLS on April 21, 2020, at 10:23:05

> Hi.
>
> I am pleased that Sage Therapeutics has continued to pursue FDA approval of zuranolone, despite the irresponsible 15-day trial performed by an ignorant group of investigators. (Even if zuranolone proves to be ineffective, that doesn't excuse such a flawed study).
>
I agree, but I don't see what is exciting about it. According to Wikipedia, it "acts as a positive allosteric modulator of the GABAA receptor.". That's just what benzodiazepines, barbiturates, and even alcohol, do.
-undopaminergic

Thread

Zuranolone (SAGE-217) Update. SLS 4/21/20
Re: Zuranolone (SAGE-217) Update. undopaminergic 4/22/20
Re: Zuranolone (SAGE-217) Update. » undopaminergic SLS 4/25/20
Re: Zuranolone (SAGE-217) Update. » SLS undopaminergic 4/25/20

Post a new follow-up

Notify the administrators

Start a new thread

poster:undopaminergic thread:1109687
URL: http://www.dr-bob.org/babble/20200303/msgs/1109692.html

	for
in